OptimizeRx Corporation

NASDAQ:OPRX

Medical - Healthcare Information Services

Healthcare
$7.31 -0.98%

-$0.05 today

Market cap
$138.21M
Beta
1.10
P/E (TTM)
13.8
EPS (TTM)
$0.36
52W Low $4.57High $22.25

Volume 0.18M

Average 0.47M

OPRX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

OptimizeRx CorporationNASDAQ: OPRX

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 18.76M shares rose 1.6% year over year, in line with the +1.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.6% holds above the trailing-twelve-month pace of +1.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
18.76M+0.5% QoQ
Last fiscal yearDec 2025
18.56M+1.4% YoY
LTMMar 2026
18.61M+1.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.6%——
1 year+1.4%——
3-year CAGR+1.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
18.56M USD
Year-over-year change
+1.4%
4-year CAGR
+1.9%

Weighted Avg Shares vs competitors

How OPRX compares with its peers on the latest reported figures

  • OPRX's LTM Mar 2026 weighted avg shares of 18.61M shares is the 7th highest of the 10 companies compared; the peer median is 20.62M shares.
  • Its year-over-year change of +1.3% is the 6th highest of 10, against a peer median of +1.6%.
  • Over three fiscal years its annual growth of +1.4% compares with a peer median of +1.8%.
OPRX Competitors Peer median
Weighted Avg Shares for OPRX and competitors
Company Period LTM YoY 3-year CAGR
DHDefinitive Healthcare Corp.LTM Mar 2026104.66M -9.4%+1.8%
SOPHSOPHiA GENETICS S.A.LTM Mar 202668.62M +3.6%+1.8%
RXSTRxSight, Inc.LTM Mar 202641.05M +3.2%+14.2%
NRCNational Research CorporationLTM Mar 202622.21M -5.4%-3.5%
SPOKSpok Holdings, Inc.LTM Mar 202620.62M +1.6%+1.6%
SLPSimulations Plus, Inc.LTM Feb 202620.14M +0.4%-0.2%
OPRXOptimizeRx CorporationLTM Mar 202618.61M +1.3%+1.4%
TBRGTruBridge, Inc.LTM Mar 202614.51M +1.3%+0.3%
NAKANakamoto Inc.LTM Mar 202611.36M +89.0%+24.5%
DRUGBright Minds Biosciences Inc.LTM Mar 20267.9M +77.0%+40.7%
Peer median (excluding OPRX) 20.62M+1.6%+1.8%

Competitors are the stored peer set for OPRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue61.29M62.45M71.52M92.13M109.43M
Cost of Revenue25.65M23.48M28.62M32.75M40.16M
Gross Profit35.64M38.97M42.9M59.38M69.27M
Gross Margin58.1%62.4%60.0%64.5%63.3%
Research & Development00000
Selling, General & Admin33.19M49.24M58.02M61.27M50.25M
Operating Expenses35.28M51.26M69.3M73.08M57.21M
Depreciation & Amortization1.97M2.02M2.4M4.33M4.33M
EBITDA2.34M(9.42M)(21.31M)(8.9M)16.57M
EBITDA Margin3.8%-15.1%-29.8%-9.7%15.1%
Operating Income361.1K(12.29M)(26.4M)(13.71M)12.06M
Operating Margin0.6%-19.7%-36.9%-14.9%11.0%
Interest Income16.98K852.3K2.19M329K353K
Interest Expense001.45M6.16M5.29M
Other Income / Expenses16.98K852.3K1.24M(5.68M)(5.11M)
Income Before Tax378.08K(11.44M)(25.16M)(19.39M)6.95M
Pre-Tax Margin0.6%-18.3%-35.2%-21.0%6.4%
Income Tax Expense00(7.6M)725K1.82M
Net Income378.08K(11.44M)(17.57M)(20.11M)5.13M
Net Margin0.6%-18.3%-24.6%-21.8%4.7%
EPS (Basic)0.02(0.64)(1.03)(1.10)0.28
EPS (Diluted)0.02(0.64)(1.03)(1.10)0.27
Weighted Avg Shares17.23M17.78M17.12M18.29M18.56M
Weighted Avg Shares (Diluted)17.69M17.78M17.12M18.29M19M

OptimizeRx Corporation

NASDAQ:OPRX

Intrinsic Alpha fair value

Locked

Current Price

$7.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.